Premium
Interferon‐alpha may restore sensitivity to tyrosine‐kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation
Author(s) -
Potenza Leonardo,
Volzone Francesco,
Riva Giovanni,
Soverini Simona,
Martinelli Silvia,
Iacobucci Ilaria,
Gnani Alessandra,
Barozzi Patrizia,
Forghieri Fabio,
Morselli Monica,
Zanetti Eleonora,
Maccaferri Monica,
Baccarani Michele,
Martinelli Giovanni,
Torelli Giuseppe,
Luppi Mario
Publication year - 2009
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2009.07747.x
Subject(s) - dasatinib , medicine , imatinib , minimal residual disease , tyrosine kinase , philadelphia chromosome , imatinib mesylate , chemotherapy , mutation , alpha interferon , cancer research , oncology , interferon , immunology , bone marrow , biology , chromosomal translocation , genetics , myeloid leukemia , receptor , gene